This article is more than 5 years old. Information may no longer be current.

Heidelberg receives FDA clearance for normative glaucoma database, software package

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VISTA, Calif. — Heidelberg Engineering has received clearance from the U.S. Food and Drug Administration for its Spectralis age-adjusted retinal nerve fiber layer thickness normative database for assessing risk and managing the progression of glaucoma, the company announced.

The Spectralis database, which is part of Heidelberg's new Spectralis Version 5.3 software suite, offers Heidelberg's FoDi fovea-to-disc alignment software and posterior pole asymmetry analysis, as well as TruTrack active eye tracking for optimized image detail and precise measurements.

Heidelberg plans to present its Spectralis software package at the American Academy of Ophthalmology meeting and to begin shipping units shortly thereafter.